2019 Full Year Results and Year in Review

Basel, February 2020. Presenting 2019 full year results Syngenta reported solid second-half growth overcomes first-half extreme weather headwinds. Sales $13.6 billion (20181: $13.6bn), 4% higher at constant exchange rates. Crop Protection sales up 1 percent, 5 percent CER., but seeds sales down 4 percent, flat at CER. EBITDA $2,927 million; $2,583 million excluding capitalized development, flat with 2018 adjusted for change of control royalties and divestments. Free cash flow $1.39 billion (2018: $1.76 billion).

Acquisitions, divestments and other significant transactions in 2019

On January 3, 2019, Syngenta divested certain crop protection products in India, pursuant to commitments given to the Indian antitrust authority Competition Commission of India relating to ChemChina’s acquisition of Syngenta.

On January 3, 2019, Syngenta completed the sale and leaseback transaction for the remaining buildings and land at its Basel site which were not disposed of in 2018.

On June 6, 2019, Syngenta acquired the cyclamen flowers business of Varinova, a specialized breeding company based in the Netherlands, in order to enhance Syngenta’s portfolio and breeding pipeline.

On August 30, 2019, Syngenta acquired The Cropio Group, an agricultural technology company with a primary focus in Eastern Europe. The Cropio platform is an equipment-integrated, end-to-end software solution that provides imaging, recordkeeping, and equipment tracking. Significant opportunities for collaboration across Syngenta’s other digital agriculture platforms are expected.

On November 1, 2019, Syngenta obtained control of Sanbei Seeds Co. Ltd., China, a former associate in which Syngenta has held a 49 percent equity ownership since 2008, as a result of the transactions and agreements involving China National Agrochemical Corporation (CNAC), a ChemChina group subsidiary.

During December 2019, as part of Syngenta’s real estate portfolio monetization strategy, Syngenta completed a sale-and-leaseback transaction for two of its global research and development sites. Syngenta Media

Source: Syngenta AG

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld\'s sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.

Back to section